Investor Relations
TSXV: NFTR
$[0.00] [+0.00 (+0.00%)]
Minimum 15 minutes delayed.
ABOUT NFTR TECHNOLOGIES, INC.
NFTR Technologies Inc. is a pre-revenue medical device company in the dental sector, focused on the development and commercialization of the NaturalFit TR™ system, a patient-specific, screw-free, one-piece tooth replacement solution and an alternative to conventional screw-based dental implants. Each NaturalFit TR™ tooth replacement is designed from cone beam computed tomography (CBCT) imaging to match the anatomy of the patient’s original tooth, and is placed at the same visit as the tooth extraction, without surgical drilling. Clinical studies of patient-specific tooth replacement, involving 450+ placements across 20 centers in six countries, ran from 2013 to 2019. The Company is advancing U.S. FDA 510(k) clearance and CE Marking under the EU Medical Device Regulation, with commercial launch targeted for 2027.
COMPANY HIGHLIGHTS
A patient-specific, one-piece, screw-free tooth replacement system, placed at the time of extraction
Leadership with deep experience in dental innovation and commercialization
450+ placed in clinical studies with multi-year follow-up
Portfolio of 11 U.S. and 4 E.U. patents
FDA 510(k) submission targeted for Q4 2026 – Q2 2027
News Releases
1317234 B.C. Ltd. And RTRS Technologies Inc. Announce Launch Of Brokered Private Placement Of Subscription Receipts For Gross Proceeds Of Up To C$5,000,000
October 14, 2026
1317234 B.C. Ltd. and RTRS Technologies Inc. Announce Execution of Definitive Agreement and Concurrent Financing
September 11, 2026
MILESTONES
2013–2019
Clinical studies
2020
RTRS Technologies founded
2026
NFTR Technologies Inc.
Proposed listing on the TSX Venture Exchange.
Q4 2026 – Q2 2027
FDA 510(k) submission and review
Following commercial manufacturing validation and bench testing.
Q1 2027
E.U. MDR registration
Q2 2027
FDA 510(k) clearance and commercial launch
Target dates are subject to regulatory review.